Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society

Provided By PR Newswire

Last update: May 19, 2023

SAN DIEGO, May 19, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced its participation in the Nasdaq Closing Bell Ceremony on May 19, 2023. The event will serve as a commemoration of National Brain Tumor Awareness Month (#GoGrayinMay), an important initiative dedicated to raising awareness and advancing research in the fight against brain cancer.